Revenue · 2015–2025
Novo Nordisk A S revenue
$46.8B+11.0% · FY2025
Novo Nordisk A S (NVO) reported $46.8B in revenue for fiscal 2025, +11.0% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $46.8B | +11.0% | Open → |
| FY20242024-12-31 | $42.1B | +25.0% | Open → |
| FY20232023-12-31 | $33.7B | +34.6% | Open → |
| FY20222022-12-31 | $25.0B | +11.9% | Open → |
| FY20212021-12-31 | $22.4B | +15.1% | Open → |
| FY20202020-12-31 | $19.5B | +6.3% | Open → |
| FY20192019-12-31 | $18.3B | +3.3% | Open → |
| FY20182018-12-31 | $17.7B | +4.5% | Open → |
| FY20172017-12-31 | $17.0B | +2.1% | Open → |
| FY20162016-12-31 | $16.6B | +3.5% | Open → |
| FY20152015-12-31 | $16.1B | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +11.3%
Figures are reported under IFRS in DKK and converted to US dollars at ECB reference rates — fiscal 2025 average 6.605 DKK/$ for income items, year-end 6.357 DKK/$ for balance-sheet items.
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novo Nordisk A S revenue |url=https://companiesranked.com/en/company/novo-nordisk-a-s/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novo Nordisk A S revenue. CompaniesRanked. https://companiesranked.com/en/company/novo-nordisk-a-s/revenueBibTeX
@misc{companiesranked-en-company-novo-nordisk-a-s-revenue-2026,
author = {{CompaniesRanked}},
title = {{Novo Nordisk A S revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novo-nordisk-a-s/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0000353278-26-000012 · February 4, 2026
{{cite web |title=Novo Nordisk A S revenue — 20-F (0000353278-26-000012) |url=https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.